dalteparin has been researched along with Empyema, Gall Bladder in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mishalov, VG | 1 |
| Terekhov, SN | 1 |
| Zaria, IL | 1 |
| Sukhoviĭ, MV | 1 |
| Semeniaka, VI | 1 |
| Aver'ianov, EV | 1 |
| Burnaeva, SV | 1 |
1 other study available for dalteparin and Empyema, Gall Bladder
| Article | Year |
|---|---|
[Correction of hemocoagulation disorders in complicated forms of acute cholecystitis].
Topics: Acute Disease; Aged; Anticoagulants; Blood Coagulation Disorders; Cholecystitis; Enoxaparin; Female; | 2002 |